David Blackburn studies various aspects of cognitive health, particularly how conditions such as Alzheimer's disease and spinal cord injury affect cognitive function. He explores the effectiveness of new treatments like lecanemab for dementia and develops systems to detect early signs of cognitive decline through speech analysis. His research also extends to studying infections such as welder’s anthrax, examining their treatment and the public health implications of outbreaks.
Key findings
In Blackburn's study on ALS, personalized cognitive testing was seen as helpful by some patients, while others feared it could affect their identity or cause distress.
In a case of welder's anthrax, the patient recovered fully after 26 days in the hospital following treatment with obiltoxaximab and antibiotics, highlighting the need for better workplace safety measures.
The CognoMemory system achieved an F1-score of 0.89 in detecting early cognitive decline, demonstrating high accuracy in identifying conditions like dementia.
Guidelines for using lecanemab suggest it should only be administered to specific patients, which could enhance care for individuals with mild dementia.
In a survey of clinicians, 68% believed cognitive impairment is more common in spinal cord injury patients, underscoring the need for better assessment tools in this group.
Frequently asked questions
Does Dr. Blackburn study dementia?
Yes, he conducts research on Alzheimer's disease and has explored treatments like lecanemab for managing mild cognitive impairment and mild dementia.
What are the applications of Dr. Blackburn's work for patients with spinal cord injuries?
His research focuses on understanding cognitive impairment in spinal cord injury patients, emphasizing the need for better assessments to support their rehabilitation.
How does Dr. Blackburn’s work help early detection of cognitive decline?
He developed the CognoMemory system which analyzes speech patterns to detect early signs of cognitive decline accurately, aiding in timely interventions.
What is the significance of the study on welder's anthrax?
It highlights the effectiveness of treatment with obiltoxaximab and the importance of improving safety measures to prevent bacterial infections in welding environments.
Can Dr. Blackburn's research benefit public health?
Yes, his work on malaria outbreaks and cognitive health has implications for public health policies and improving care for at-risk communities.
Publications in plain English
A Causal Validation augmented Temporal Convolutional Framework for Brain Effective Connectivity Networks Estimation.
2026
Neural networks : the official journal of the International Neural Network Society
Dong A, Cao J, Sarrigiannis PG, Blackburn D, Starr A +1 more
Plain English This study focused on improving how we understand brain connectivity, which is important for learning about brain functions and diseases like Alzheimer's and Parkinson's. Researchers introduced a new method called the Causal Validation augmented Temporal Convolutional Framework (CVTCF), which better detects how different parts of the brain influence each other and reduces unnecessary data. Their approach outperformed existing methods in tests, showing it can help analyze brain interactions tied to neurological diseases, potentially aiding in diagnosis and treatment.
Who this helps: This helps patients with neurodegenerative diseases and their doctors.
Patient and caregiver attitudes to cognitive and behavioral testing in Amyotrophic Lateral Sclerosis.
2026
Neurodegenerative disease management
Ing L, Griffiths AW, Mayberry E, Ali Y, Blackburn D +1 more
Plain English This study looked at how patients with Amyotrophic Lateral Sclerosis (ALS) and their caregivers feel about cognitive and behavioral testing. Researchers interviewed 10 patients and 9 caregivers, finding that while some saw testing as a helpful tool for planning and maintaining control, others were worried it might affect their identity or cause distress. The study highlights that for cognitive testing to be effective, it needs to be personalized, introduced with care, and connected to meaningful actions.
Who this helps: This helps patients with ALS and their caregivers by improving how cognitive testing is approached in their care.
Welder's Anthrax Treated with Obiltoxaximab - Louisiana, 2024.
2026
MMWR. Morbidity and mortality weekly report
Thompson JM, Lundstrom EW, Hein LD, Beesley CA, Marston CK +25 more
Plain English The study focused on a case of welder's anthrax in an 18-year-old man from Louisiana who developed severe pneumonia and needed intensive medical care. After being treated with a special antitoxin called obiltoxaximab along with other antibiotics, he showed rapid improvement and was discharged in 26 days, with no lingering symptoms by his 3-month check-up. These findings highlight the importance of recognizing welder's anthrax as a potential cause of pneumonia in metalworkers, especially in the southern U.S., and the need for better workplace safety measures.
Who this helps: This helps metalworkers and healthcare providers by improving awareness and treatment options for anthrax-related illnesses.
Improving current understanding of cognitive impairment in patients with a spinal cord injury: A UK-based clinician survey.
2025
The journal of spinal cord medicine
Patel H, Blackburn D, Hariharan R, Nair KPS, Bell SM
Plain English This study looked at how doctors assess cognitive impairment in patients with spinal cord injuries in the UK. Out of 41 clinicians surveyed, 68% believed that cognitive impairment is more common in these patients, but 15% did not use any assessment tools because they found them too challenging or time-consuming. This is important because without proper screening, patients might be missing out on necessary support and care that could help them with rehabilitation and daily living.
Who this helps: This benefits patients with spinal cord injuries and their healthcare providers.
Back-Contact Perovskite Solar Cell Modules Fabricated via Roll-to-Roll Slot-Die Coating: Scale-Up toward Manufacturing.
2025
ACS applied energy materials
Blackburn D, Hill NS, Wood CJ, Velusamy T, Nieto-Díaz BA +18 more
Plain English This study focuses on making a new type of solar cell using a special coating method that produces them quickly and cheaply. The researchers developed solar cells that do not use rare or expensive materials, making them more sustainable and affordable. This method can mass-produce these solar cells, which could lead to widespread use of renewable energy.
Who this helps: This benefits consumers looking for affordable solar energy options and manufacturers in the renewable energy sector.
Back-Contact Perovskite Solar Cells: Progress, Challenges and the Future.
2025
ACS applied materials & interfaces
Blackburn D, Hill NS, Sirbu D, Lidzey DG
Plain English This study looked at a new type of solar cell called back-contact solar cells, which use perovskite materials instead of traditional methods. Since 2016, the efficiency of these solar cells has increased significantly, reaching up to 12.8%, making them a promising option for future use. The research highlights the advantages of these cells, such as easier manufacturing processes, while also addressing the challenges that need to be overcome for widespread production.
Who this helps: This benefits renewable energy developers and consumers looking for more efficient and cost-effective solar power options.
Public Health Response to the First Locally Acquired Malaria Outbreaks in the US in 20 Years.
2025
JAMA network open
DeVita TN, Morrison AM, Stanek D, Drennon M, Sarney E +21 more
Plain English In 2023, the US saw 10 locally acquired malaria cases across four states, marking the first such outbreak in 20 years. The patients, who had no recent travel history, were 70% male with an average age of about 39. Researchers found that the malaria strains in Florida were linked to a specific local source, while Texas and Arkansas strains were different. This outbreak matters because it highlights a resurgence of malaria risk in the US and the need for strong public health measures to prevent further cases.
Who this helps: This information benefits public health officials, doctors, and communities in affected areas.
Improving current understanding of cognitive impairment in spinal cord injury: The patient perspective.
2025
The journal of spinal cord medicine
Patel H, Knox L, Blackburn D, Bartlett C, Sproson L +3 more
Plain English This study looked at how people with spinal cord injuries (SCI) experience cognitive problems, such as memory and thinking issues. The researchers held focus groups with nine participants, who reported various cognitive difficulties after their injuries and emphasized that they often lacked information and assessments about these issues. All participants wanted healthcare providers to pay more attention to cognitive health, as it can affect their rehabilitation and overall quality of life.
Who this helps: This benefits patients with spinal cord injuries and healthcare providers.
Immune Profiling in Early Cognitive Disorders (IMPRINT) study protocol: a longitudinal cohort study exploring biomarkers of inflammation in early dementia with Lewy bodies and Alzheimer's disease, as part of the Dementias Platform UK.
2025
BMJ open
Crook H, Swann P, Fye H, Kigar S, Savulich G +12 more
Plain English The IMPRINT study is investigating how inflammation in the body relates to early signs of dementia, specifically in conditions like Alzheimer's disease and dementia with Lewy bodies. The researchers are collecting samples from both patients with early symptoms and healthy participants to identify specific immune patterns over time. Understanding these patterns may help predict disease progression and cognitive decline.
Who this helps: This research benefits patients with early dementia and their doctors by providing insights into potential early detection and treatment strategies.
Automatic Detection of Early Cognitive Decline Using Multimodal Feature Fusion and Transfer Learning on Real-World Conversational Speech.
2025
IEEE journal of biomedical and health informatics
Pahar M, Mirheidari B, Illingworth C, Braun D, Tao F +3 more
Plain English This study focused on a new system called CognoMemory that detects early signs of cognitive decline, like dementia and mild cognitive impairment, by analyzing how people speak. Researchers collected over 307 hours of conversation from 1,639 individuals and developed a method that uses both sound and language patterns to identify these conditions accurately. The system showed high accuracy, with F1-scores reaching 0.89 in testing, which means it is effective in recognizing cognitive decline early, helping to address these issues before they worsen.
Who this helps: This benefits patients at risk for cognitive decline and their doctors by providing a quick and reliable way to identify problems early.
Lecanemab appropriate use recommendations for clinical practice in the UK.
2025
Journal of neurology, neurosurgery, and psychiatry
Mummery CJ, Rasmussen J, Blackburn D, Coulthard E, Davies RR +18 more
Plain English This study focused on how lecanemab, a new treatment for mild cognitive impairment and mild dementia from Alzheimer's disease, should be used in the UK. Experts established guidelines ensuring that only certain patients, specifically those with confirmed brain amyloid levels and without specific genetic risk factors, can receive the treatment safely. Lecanemab could significantly enhance care for individuals with dementia, improving overall management and support services even for those not receiving this medication.
Who this helps: This helps patients with mild dementia and healthcare providers.
Hadjivassiliou M, Blackburn D, O'Malley R, Hoggard N
Plain English This study examined a male patient with a rare condition called IgG4 disease, which led to problems with balance (cerebellar ataxia) and changes in behavior due to brain issues (frontotemporal dementia). The researchers found that the patient's brain imaging showed shrinkage in a specific area of the brain and there were signs of inflammation around his aorta and kidneys, confirmed by a biopsy. Although treatment with steroids and other medications improved his condition, he eventually developed severe complications and died, marking the first time such neurological symptoms have been associated with IgG4 disease.
Who this helps: This information benefits doctors and researchers by increasing awareness of the neurological effects of IgG4 disease.
Dementia classification using a graph neural network on imaging of effective brain connectivity.
2024
Computers in biology and medicine
Cao J, Yang L, Sarrigiannis PG, Blackburn D, Zhao Y
Plain English This study focused on using a new computer model called a graph neural network to analyze brain scans and better classify Alzheimer's disease and Parkinson's disease compared to healthy individuals. The researchers found that their method achieved high accuracy rates—94% for differentiating Alzheimer's from healthy patients, 94.2% for Parkinson's from healthy patients, and 97.4% for separating Alzheimer's from Parkinson's. This work is important because it could lead to faster and more accurate diagnoses of these common diseases, which can help in providing better patient care.
Who this helps: Patients with Alzheimer's and Parkinson's, as well as doctors diagnosing these conditions.
Metabolic model predictions enable targeted microbiome manipulation through precision prebiotics.
2024
Microbiology spectrum
Marinos G, Hamerich IK, Debray R, Obeng N, Petersen C +10 more
Plain English This study looked at how to boost the levels of beneficial bacteria in our bodies, specifically one called MYb11, by using specific prebiotics. The researchers identified four prebiotics—L-serine, L-threonine, D-mannitol, and γ-aminobutyric acid—that increased MYb11 levels, with L-serine showing particularly strong effects even in living worms. This research is important because it could lead to new treatments that enhance healthy bacteria in our microbiomes, helping us improve health outcomes.
Who this helps: Patients looking for better treatments for diseases influenced by their microbiome.
Video Education and Behavior Contract to Improve Outcomes After Renal Transplantation (VECTOR): A Randomized Controlled Trial.
2024
Patient preference and adherence
Mansell H, Rosaasen N, Wichart J, West-Thielke P, Blackburn D +9 more
Plain English This study looked at whether providing kidney transplant patients with video education and a behavior contract would help them take their anti-rejection medications more consistently. Out of 203 patients, those who received this extra support showed no improvements in medication adherence or overall health outcomes compared to those who only received standard education. The findings highlight that simply adding video tools and contracts is not enough to solve the complex issue of medication nonadherence after a transplant.
Who this helps: This helps kidney transplant patients.
Philosophical transactions. Series A, Mathematical, physical, and engineering sciences
Acres J, Antoniou I, Christie F, Blackburn D, Knight S
Plain English This research looked at a new kind of power plant called the Spherical Tokamak for Energy Production (STEP) that aims to produce more than 100 megawatts (MWe) of electrical power for the national grid. The study examined how the plant would generate energy by cooling the tokamak, converting heat into electricity, and managing energy distribution. The findings show that the design is on track to successfully generate net power, which is crucial for making fusion energy a viable option.
Who this helps: This benefits energy producers and consumers by paving the way for clean, sustainable power generation.
Comparative Genomic Analysis ofand Closely Related Species.
2024
bioRxiv : the preprint server for biology
Hughes Lago C, Blackburn D, Kinder Pavlicek M, Threadgill DS
Plain English This study focused on a type of bacteria called **C. curvatus**, which is linked to gum disease and other serious infections. Researchers sequenced eight new strains of this bacterium and discovered that they share 2,670 genes, with some key systems for infection missing in certain strains, such as the type IV secretion system in five of them. This matters because understanding the genetic differences among these bacteria can help doctors identify infections more accurately and develop better treatments.
Who this helps: Patients suffering from periodontal disease and infections.
Seroprevalence and Risk Factors for Toxoplasma gondii Infection in Women of Reproductive Age in Nigeria in 2018.
2024
The American journal of tropical medicine and hygiene
Blackburn D, Mba N, Nwachukwu W, Zhou H, Hill A +12 more
Plain English The study looked at the presence of Toxoplasma gondii infection among women of reproductive age in Nigeria. It found that 26.8% of the 44,269 women tested had been exposed to this infection, with higher rates in women aged 25 to 44 compared to younger women. Understanding the levels of infection and the factors that contribute to it is crucial because T. gondii can lead to serious issues during pregnancy, such as miscarriages and developmental problems in babies.
Who this helps: This helps women of reproductive age in Nigeria and healthcare providers working with them.
The First Step in Triadic Decision-Making Involving People with Dementia: Determining Who Talks When.
2024
Research on language and social interaction
Windeatt-Harrison IL, Walker T, Bell SM, Blackburn D, Dickson JM +3 more
Plain English This research studied how conversations happen in medical appointments involving patients with dementia and their companions. The findings showed that using "you" when speaking to patients helps them participate more effectively in decisions, whereas using "she" or "he" tends to exclude them. This matters because ensuring that patients with dementia can actively engage in discussions about their treatment can lead to better decision-making and care.
Who this helps: Patients with dementia and their caregivers benefit from these findings.
Effectiveness of Endophytic and Rhizospheric Bacteria fromspp. in ControllingDamping-Off of Cabbage.
2023
Plants (Basel, Switzerland)
Al-Rahbi BAA, Al-Sadi AM, Al-Harrasi MMA, Al-Sabahi JN, Al-Mahmooli IH +2 more
Plain English This study looked at bacteria found in plants and soil in Oman to see if they could help control damping-off disease in cabbage. The researchers identified 12 bacteria from inside plants and 27 from the soil, finding that one strain, named MPE1, reduced the disease by 59% in cabbage. This matters because it shows a natural way to protect crops, potentially reducing the need for chemical treatments.
Who this helps: Farmers and agricultural specialists working with cabbage crops.
Metabolic model predictions enable targeted microbiome manipulation through precision prebiotics.
2023
bioRxiv : the preprint server for biology
Marinos G, Hamerich IK, Debray R, Obeng N, Petersen C +10 more
Plain English This study focused on finding a way to influence specific beneficial bacteria in the microbiome using specially designed prebiotic substances that only feed certain microbes. The researchers predicted four compounds that could increase the number of a helpful bacteria called MYb11, with one compound, L-serine, leading to a notable boost in this bacteria when tested in a worm host. This research is important because it provides a new method for potentially improving health by precisely manipulating the microbiome, rather than using broader, less targeted techniques that can have side effects.
Who this helps: This helps patients looking for targeted treatments for microbiome-related health issues.
Application of Flow Vermimetry for Quantification and Analysis of the Caenorhabditis elegans Gut Microbiome.
2023
Journal of visualized experiments : JoVE
Zhang F, Blackburn D, Hosea CN, Assié A, Samuel BS
Plain English This study looked at how to measure and analyze the tiny organisms living in the guts of a small worm called Caenorhabditis elegans. The researchers developed a method using a special machine to count and study these microbes, which can tell us a lot about how they affect the worm's health and development. They found that this approach can accurately capture the different types of microbes in the worm's gut, making it easier to understand their role in health.
Who this helps: This benefits researchers and scientists studying gut health in various organisms, including humans.
Outbreak of Locally Acquired Mosquito-Transmitted (Autochthonous) Malaria - Florida and Texas, May-July 2023.
2023
MMWR. Morbidity and mortality weekly report
Blackburn D, Drennon M, Broussard K, Morrison AM, Stanek D +52 more
Plain English Researchers reported eight cases of locally transmitted malaria in Florida and Texas between May and July 2023, marking the first instances of this disease in the U.S. since 2003. These cases are caused by the malaria parasite Plasmodium vivax, and while the overall risk of local malaria is still very low in the U.S., doctors should consider malaria as a potential diagnosis for patients with unexplained fevers in these areas. This matters because early diagnosis and treatment can prevent severe illness and stop the disease from spreading further.
Who this helps: This helps patients and doctors by raising awareness of malaria risks in local communities.
The Impact of Age and Sex Concordance Between Patients and Physicians on Medication Adherence: A Population-Based Study.
2022
Patient preference and adherence
Yao S, Lix L, Teare G, Evans C, Blackburn D
Plain English This study looked at whether having the same age or being the same sex as a patient affects how well they stick to their statin medication regimen. Out of nearly 52,000 new patients starting statins, just over 20% were the same age as their doctors, and about 63% were the same sex. The results showed that neither age nor sex matching was significantly linked to better adherence to medication, though there was a slight indication that same-sex doctor-patient pairs might have a marginally better adherence rate.
Who this helps: This research benefits doctors by helping them understand the factors that may influence patient medication adherence.
Cost-related nonadherence can be explained by a general nonadherence framework.
2022
Journal of the American Pharmacists Association : JAPhA
Alefan Q, Cheekireddy VM, Blackburn D
Plain English This study looked at how financial issues affect people's ability to stick to their medication plans, called cost-related nonadherence (CRNA). Researchers reviewed 58 studies from 2008 to 2020 and found that both economic pressures and personal factors like health and doctor interactions play important roles in whether people take their medications as prescribed. Interestingly, poor health was linked to more nonadherence in the context of cost, while better health usually means more adherence in general medication habits. The findings highlight that financial struggles are a common barrier for patients needing medications, but understanding CRNA requires considering both financial and non-financial factors.
Who this helps: Patients who face medication costs and healthcare providers trying to improve adherence.
An integrated continuity of care measure improves performance in models predicting medication adherence using population-based administrative data.
2022
PloS one
Yao S, Lix L, Teare G, Evans C, Blackburn D
Plain English This study looked at how continuity of care (the consistency of seeing the same doctor) affects whether patients take their statin medications regularly. Researchers analyzed data from over 55,000 new statin users in Saskatchewan, Canada, and found that a more comprehensive measure of continuity, which included visits, prescriptions, and medical exams, was linked to better medication adherence. Specifically, this integrated measure was associated with a 56% higher chance of patients taking their medication as prescribed, compared to just a 23% increase when considering only physician visits.
Who this helps: This benefits patients who need to take statins, as well as their doctors in managing medication adherence.
Keeping patient and public partnership at the heart of medical technology development during Covid-19: examples of adaptive practice.
2022
Journal of medical engineering & technology
Sproson L, Mills N, Pryde L, Adebajo A, Coyle D +4 more
Plain English This research looked at how two medical organizations kept patients and the public involved in the development of medical technology during the challenges of the COVID-19 pandemic. They found that by adapting their practices, they could still successfully engage with patients, which is crucial for creating effective health solutions. The study highlights the importance of continuing to involve these groups to improve medical technology and ensure it meets real needs.
Who this helps: This helps patients and the doctors who serve them.
Ultra-high-resolution time-frequency analysis of EEG to characterise brain functional connectivity with the application in Alzheimer's disease.
2022
Journal of neural engineering
Cao J, Zhao Y, Shan X, Blackburn D, Wei J +3 more
Plain English This study explored a new way to analyze brain activity in people with Alzheimer's disease using a technique called electroencephalogram (EEG). Researchers found that their method could accurately distinguish Alzheimer's patients from healthy individuals about 89% of the time, which is better than previous methods. This matters because it could lead to a reliable new way to diagnose Alzheimer's early, helping doctors and patients get the support they need sooner.
Who this helps: This helps patients with Alzheimer's disease and their doctors.
Bispectrum-based Cross-frequency Functional Connectivity: Classification of Alzheimer's disease.
2022
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Klepl D, He F, Min W, Blackburn D, Sarrigiannis P
Plain English This study looked at how brain signals change in Alzheimer's disease (AD) by examining both traditional frequency analysis and a new method that analyzes connections between different frequency bands. Researchers found that using the new method, called cross-bispectrum analysis, provided more accurate results in identifying AD, improving classification accuracy compared to traditional methods. Specifically, while both approaches could predict AD effectively, the cross-bispectrum method was better, highlighting the importance of looking at how different brain wave frequencies interact.
Who this helps: This helps patients and doctors by improving diagnostic accuracy for Alzheimer's disease.
Blackburn D, Minhaj FS, Al Hammoud R, Orciari L, Miller J +13 more
Plain English In late August 2021, a 7-year-old boy in Texas was bitten by a bat but didn’t receive rabies treatment because there were no visible wounds, and his family didn't realize the risk. Two months later, he developed severe symptoms and was diagnosed with rabies, unfortunately passing away 22 days after the onset of symptoms. This tragic case highlights the importance of immediate rabies treatment after potential exposure to bats, as rabies is almost always fatal without prompt care, and emphasizes the need for better public awareness about rabies and access to preventive treatment.
Who this helps: This helps patients, families, and communities by promoting awareness and education about rabies risks and prevention.
Epidemiologic and Clinical Features of Mpox in Transgender and Gender-Diverse Adults - United States, May-November 2022.
2022
MMWR. Morbidity and mortality weekly report
Blackburn D, Roth NM, Gold JAW, Pao LZ, Olansky E +6 more
Plain English This study looked at monkeypox cases in transgender and gender-diverse adults in the U.S. from May to November 2022. Out of 28,730 total cases, 466 were among transgender and gender-diverse individuals, representing 1.7% of reported cases; most of these cases were found in transgender women (43.1%) and gender-diverse individuals (42.1%). The findings show that many in this group had close contact with cisgender men who were likely in high-risk networks, emphasizing the need for targeted health strategies to prevent monkeypox in these communities.
Who this helps: This helps transgender and gender-diverse individuals at higher risk for monkeypox.
Evaluation of a medication safety and adherence program within a First Nations community in Saskatchewan, Canada.
2021
Journal of the American Pharmacists Association : JAPhA
Erker R, Alefan Q, Goodridge D, Crawley A, Rabbitskin N +2 more
Plain English This study looked at how having a pharmacist work directly with patients in a First Nations health center in Saskatchewan helped people stick to their medication for chronic health problems. After the pharmacist joined the healthcare team, patients refilled their medications more often—showing more adherence—compared to the six months prior to their involvement. This is important because better medication adherence can lead to improved health and well-being for these patients.
Who this helps: This helps patients living with chronic health conditions in First Nations communities.
Neurologists' perceptions of utilising tele-neurology to practice remotely during the COVID-19 pandemic.
2021
Patient education and counseling
Courtney E, Blackburn D, Reuber M
Plain English This study looked at how neurologists felt about using remote consultations, like phone and video calls, during the COVID-19 pandemic. They found that while over 80% of neurologists reported feeling less satisfied with their jobs due to these changes, they also recognized that tele-neurology could improve access to care. However, it was clear that in-person visits are still necessary for some patients and types of consultations, and upgrades to technology and support are needed for tele-neurology to work effectively.
Who this helps: This benefits patients who need access to neurology services and doctors adapting to new consultation methods.
Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study.
2021
BMJ open
Evans C, Marrie RA, Yao S, Zhu F, Walld R +3 more
Plain English This study looked at how well patients with multiple sclerosis (MS) stick to their medication compared to those with other chronic diseases like epilepsy, Parkinson's disease, and rheumatoid arthritis. Researchers found that 73% of MS patients took their drugs as prescribed, while only 29% of those with epilepsy, 42% with Parkinson's, and 26% with rheumatoid arthritis did the same. This is important because it suggests that the specialized support programs for MS patients may lead to better medication adherence, and similar approaches could help patients with other chronic illnesses too.
Who this helps: This benefits patients with chronic diseases, especially those with epilepsy, Parkinson's disease, and rheumatoid arthritis.
Population scale nucleic acid delivery to Caenorhabditis elegans via electroporation.
2021
G3 (Bethesda, Md.)
Khodakova AS, Vilchis DV, Blackburn D, Amanor F, Samuel BS
Plain English This study focused on finding a better way to deliver genetic materials, like RNA, to the tiny roundworm Caenorhabditis elegans to help researchers study its biology. The researchers developed a method called electroporation, which lets them quickly and effectively introduce RNA into many worms at once, resulting in successful genetic changes in about 80% of the worms treated. This new method allows scientists to conduct larger and more complex experiments, making it easier to understand genetics in a simple organism.
Who this helps: This benefits researchers working with genetic studies in worms and potentially other organisms.
Impact of comorbidity on hospitalizations in individuals newly diagnosed with multiple sclerosis: A longitudinal population-based study.
2020
Multiple sclerosis and related disorders
Al-Sakran L, Marrie RA, Blackburn D, Knox K, Evans C
Plain English This study looked at how having other health conditions, called comorbidities, affects hospitalization rates in people newly diagnosed with multiple sclerosis (MS). Researchers found that individuals with at least one comorbidity were 72% more likely to be hospitalized for any reason compared to those without comorbidities. However, having these other conditions did not increase the chances of being hospitalized specifically for MS. This is important because it highlights the need for doctors to address other health issues in MS patients, particularly early in their treatment, to help reduce overall hospital visits.
Who this helps: This helps patients with multiple sclerosis and their doctors.
The course of asthma: A population-based 10-year study examining asthma remission in children diagnosed with asthma in preschool.
2020
Pediatric pulmonology
Oluwole O, Rennie DC, Goodridge D, Blackburn D, Litzenberger T +2 more
Plain English This study looked at how asthma changes over time in children diagnosed when they were in preschool. Researchers found that 37 out of every 100 children experienced remission from asthma over a 10-year follow-up. Children who had symptoms early in life (by age 3), girls, and those living in rural or certain urban areas were more likely to stop experiencing asthma symptoms, while those with a history of allergic conditions had a lower chance of remission.
Who this helps: This research benefits children with asthma and their doctors by providing insights into the likelihood of asthma remission.
Understanding the links between hearing impairment and dementia: development and validation of the Social and Emotional Impact of Hearing Impairment (SEI-HI) questionnaire.
2020
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Littlejohn J, Blackburn D, Venneri A
Plain English This study created and tested a new questionnaire called the Social and Emotional Impact of Hearing Impairment (SEI-HI) to see how hearing difficulties affect social and emotional well-being and if these factors relate to the risk of dementia. The researchers confirmed that the SEI-HI is reliable and easy to use, with positive responses from 31 patients with mild cognitive issues. Understanding these links is important because hearing impairment may increase the risk of dementia, and addressing related social and emotional challenges could improve patient care.
Who this helps: Patients with hearing impairment and cognitive decline, as well as their healthcare providers.
Saxon JA, Thompson JC, Harris JM, Ealing J, Hamdalla H +9 more
Plain English This study looked at how effective the Edinburgh Cognitive and Behavioral ALS Screen (ECAS) is for detecting a type of dementia called behavioral variant frontotemporal dementia (bvFTD). Researchers tested 20 patients with ALS-FTD, 23 with bvFTD, and 30 healthy individuals. They found that patients with any form of dementia performed worse on cognitive tasks compared to healthy controls, and while both patient groups scored similarly overall, those with ALS-FTD struggled more with verbal fluency.
Who this helps: This helps doctors better assess cognitive issues in patients with ALS-FTD and bvFTD, leading to improved diagnosis and care.
Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis.
2020
Journal of neurology, neurosurgery, and psychiatry
Saxon JA, Thompson JC, Harris JM, Richardson AM, Langheinrich T +11 more
Plain English This study looked at the differences in thinking and behavior between patients with frontotemporal dementia (FTD) that also have amyotrophic lateral sclerosis (ALS) and those with just FTD. Researchers tested 23 patients with FTD alone, 20 with FTD-ALS, and 30 healthy individuals. They found that while both groups of patients struggled more than healthy controls, those with just FTD showed more severe behavioral changes, like impulsiveness and loss of empathy, while those with FTD-ALS mostly experienced apathy.
Who this helps: This research benefits doctors and caregivers by improving their understanding of the differences between FTD and FTD-ALS when caring for patients.
Fully automated cognitive screening tool based on assessment of speech and language.
2020
Journal of neurology, neurosurgery, and psychiatry
O'Malley RPD, Mirheidari B, Harkness K, Reuber M, Venneri A +3 more
Plain English Researchers developed a computer program called "CognoSpeak" to help identify different types of cognitive issues, like Alzheimer’s disease and mild cognitive impairment, based on how people speak. In a study with 60 participants, the program accurately distinguished between those with serious cognitive problems and those with no issues 86.7% of the time, and correctly identified mild cognitive impairment cases 80% of the time. This tool matters because it can potentially allow doctors to identify patients who are less likely to have dementia more quickly, helping reduce the strain on memory clinics.
Who this helps: Patients with memory concerns and their doctors.
Biomarker Testing: Piercing the Fog of Alzheimer's and Related Dementia.
2020
Biomedicine hub
Horgan D, Nobili F, Teunissen C, Grimmer T, Mitrecic D +7 more
Plain English This study examined how biomarker tests can improve the early detection and diagnosis of Alzheimer's disease and related dementias, which are increasingly taxing health systems. It highlights that currently available biomarkers could significantly benefit patients and healthcare systems if used more widely, potentially leading to earlier diagnosis and better management of the disease. The paper calls for action from policymakers to enhance access to these tests, which could lead to more effective care for those affected.
Who this helps: This helps patients with Alzheimer's and their families, as well as healthcare providers looking for better diagnosis tools.
, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts.
2020
Neurology
Costa B, Manzoni C, Bernal-Quiros M, Kia DA, Aguilar M +106 more
Plain English In this study, researchers looked at how genetic factors, like ancestry and age when symptoms appear, affect different types of frontotemporal lobar degeneration (FTLD), specifically behavioral variant frontotemporal dementia (bvFTD) and primary progressive aphasia (PPA). They found that 4% of the 1,396 cases had genetic changes linked to the disease, with bvFTD patients showing a higher rate of these changes at 5%, compared to just 0.8% in PPA patients. This information helps doctors better understand the genetic risks associated with these conditions, which could lead to more accurate diagnoses and targeted treatments.
Who this helps: Patients with frontotemporal dementia and their doctors.
Cognitive deficits in vasculitis of the nervous system: a cross-sectional study.
2019
Postgraduate medicine
Mullin E, Aristotelidou V, Blackburn D, Jenkins T, Hadjivassiliou M
Plain English This study looked at how vasculitis, which affects the nervous system, impacts thinking and daily functioning in patients. Out of 67 patients, those with Central Nervous System (CNS) vasculitis scored an average of 74 out of 100 on a cognitive test, indicating significant cognitive impairment, while patients with Peripheral Nervous System (PNS) vasculitis scored better, averaging 87. Understanding these deficits is crucial because it highlights the need for targeted therapy and support for those struggling with cognitive issues due to CNS vasculitis.
Who this helps: This helps patients with CNS vasculitis and their healthcare providers.
Role of the Photorhabdus Dam methyltransferase during interactions with its invertebrate hosts.
2019
PloS one
Payelleville A, Blackburn D, Lanois A, Pagès S, Cambon MC +4 more
Plain English This study looked at a specific gene called “dam” in a type of bacteria, Photorhabdus luminescens, which partners with a nematode (a type of worm). The researchers found that increasing the amount of the dam gene didn't change how well the bacteria and nematode worked together, but it did improve how long the nematode-bacterial pair could survive in insects, increasing their survival time by a significant amount. This knowledge may help understand the interactions between pathogens and their hosts and how they might be used in pest control strategies.
Who this helps: This benefits researchers studying pest control and potentially farmers looking for agricultural solutions.
Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study.
2019
BMJ open
Al-Sakran L, Marrie RA, Blackburn D, Knox K, Evans C
Plain English This study looked at how the use of disease-modifying therapies (DMTs) for multiple sclerosis (MS) affected healthcare usage among the population in Saskatchewan, Canada, from 1997 to 2016. The findings showed that for every 1,000 times DMTs were dispensed, hospitalizations for any reason decreased by about 0.6% and for MS specifically by about 9.1%. However, the number of visits to doctors did not change significantly with increased DMT use, indicating that while DMTs help reduce hospital stays, they don’t seem to lower the need for physician visits.
Who this helps: This benefits patients with multiple sclerosis by highlighting how DMTs can improve their overall health and reduce hospital stays.